Dronabinol
Back to searchMolecule Structure
Scientific Name
Dronabinol
Description of the Drug
Dronabinol is a synthetic delta-9-THC used in the treatment of anorexia and weight loss in HIV patients as well as nausea and vomiting in cancer chemotherapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00470
http://www.drugbank.ca/drugs/DB00470
Brand Name(s)
Dronabinol, Marinol, Syndros
Company Owner(s)
Alkem Laboratories Ltd, Ascent Pharmaceuticals Inc, Svc Pharma Lp, Lannett Co Inc, Insys Therapeutics Inc, Benuvia Therapeutics Inc, Akorn Operating Co Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cannabinoid CB1 receptor | SINGLE PROTEIN | AGONIST | CHEMBL218 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4609 | ||
| PharmGKB | PA449421 | ||
| Human Metabolome Database | HMDB0014613 | ||
| DrugBank | DB00470 | ||
| PubChem: Thomson Pharma | 14899056 | 14776764 | |
| PubChem | 16078 | ||
| NMRShiftDB | 40265338 | ||
| Nikkaji | J882F | ||
| PDBe | TCI | ||
| BindingDB | 60994 | ||
| EPA CompTox Dashboard | DTXSID6021327 | ||
| LipidMaps | LMPK13120004 | ||
| DrugCentral | 4109 | ||
| Metabolights | MTBLC66964 | ||
| Brenda | 224503 | 135425 | |
| Rhea | 66964 | ||
| Guide to Pharmacology | 2424 | ||
| rxnorm | SYNDROS | DRONABINOL | MARINOL |
| PubChem: Drugs of the Future | 12013925 | ||
| KEGG Ligand | C06972 | ||
| ChEBI | 66964 | ||
| ZINC | ZINC000001530625 |
